Anita Müller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anita Müller has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Anne Brédart
Psycho-Oncology Unit, Supportive Care Department, Institut Curie, 75005 Paris, France
5 shared publications - Sylvie Dolbeault
Institut Curie, Supportive Care Department, Psycho-Oncology Unit, 26, rue d'Ulm, 75005 Paris cedex 05, France; U1018, Inserm, U1018, Research Centre in Epidemiology and Population Health (CESP), University Paris-Sud, Villejuif, France
4 shared publications - Bernhard Holzner
Medical University of Innsbruck
2 shared publications - Charles Martin-Krumm
Interdisciplinarite en Sante Publique, Interventions et Instruments de Mesure Complexes, Region Est, Unite Mixte de Recherche, University of Lorraine
2 shared publications - Manuel Rodrigues
Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Institut Curie, PSL Research University, Paris, France
2 shared publications - Morgan Dondin
Psycho-Oncology Unit, Supportive Care Department, Institut Curie, 75005 Paris, France
2 shared publications
Latest Publications
- Open Access
Psychosocial Interventions in Cancer Survivorship: A Rapid Scoping Review of the Recent PubMed-Indexed Literature
Background/Objectives: In recent years, the number of cancer survivors has increased. Psychological difficulties or disorders are frequent during survivorship (e.g., fear of cancer recurrence, anxiety, depression, and insomnia). Various interventions have been developed to address survivors’ specific psychosocial needs. This rapid scoping review aimed to define the interventions that have been developed for adult cancer survivors by describing (1) the type of intervention, (2) their measured psychosocial outcome variables, and (3) participants’ main characteristics. Methods: PubMed was searched for articles published between 2020 and 2025. The search strategy combined terms related to cancer survivorship, psychosocial outcomes, and interventions. Titles and abstracts were screened, and data were extracted using a structured form specifying study type, population, intervention, and outcome characteristics. PRISMA-ScR guidelines were followed. Results: Out of 1743 screened studies, 80 were included (67 studies, 13 systematic reviews/meta-analyses), representing approximately 7880 cancer survivors (from the n = 67). Nearly 45% of included studies were conducted in the United States, and most interventions were developed for breast cancer survivors (38.8%) or included a majority of female participants. Physical activity (22.39%), psychoeducation (17.9%), and cognitive behavioural therapy (16.4%) were the most common intervention types. About a third incorporated eHealth or telehealth. Two-thirds of studies (65.7%) reported predominantly positive effects on psychosocial outcomes. Few interventions included cultural adaptations and targeted minority or socioeconomically disadvantaged populations. Conclusions: Most interventions for cancer survivors targeted breast cancer, female survivors in high-income countries. Developing and implementing culturally adapted and cost-efficient interventions, particularly for underrepresented survivor groups, remains a priority for future research and implementation.
Open AccessPsychosocial Interventions in Cancer Survivorship: A Rapid Scoping Review of the Recent PubMed-Indexed Literature
Background/Objectives: In recent years, the number of cancer survivors has increased. Psychological difficulties or disorders are frequent during survivorship (e.g., fear of cancer recurrence, anxiety, depression, and insomnia). Various interventions have been developed to address survivors’ specific psychosocial needs. This rapid scoping review aimed to define the interventions that have been developed for adult cancer survivors by describing (1) the type of intervention, (2) their measured psychosocial outcome variables, and (3) participants’ main characteristics. Methods: PubMed was searched for articles published between 2020 and 2025. The search strategy combined terms related to cancer survivorship, psychosocial outcomes, and interventions. Titles and abstracts were screened, and data were extracted using a structured form specifying study type, population, intervention, and outcome characteristics. PRISMA-ScR guidelines were followed. Results: Out of 1743 screened studies, 80 were included (67 studies, 13 systematic reviews/meta-analyses), representing approximately 7880 cancer survivors (from the n = 67). Nearly 45% of included studies were conducted in the United States, and most interventions were developed for breast cancer survivors (38.8%) or included a majority of female participants. Physical activity (22.39%), psychoeducation (17.9%), and cognitive behavioural therapy (16.4%) were the most common intervention types. About a third incorporated eHealth or telehealth. Two-thirds of studies (65.7%) reported predominantly positive effects on psychosocial outcomes. Few interventions included cultural adaptations and targeted minority or socioeconomically disadvantaged populations. Conclusions: Most interventions for cancer survivors targeted breast cancer, female survivors in high-income countries. Developing and implementing culturally adapted and cost-efficient interventions, particularly for underrepresented survivor groups, remains a priority for future research and implementation.
- 23 September 2026
- Published by Taylor & Francis in Future Oncology
- Vol. 22 (23) , 2735-2737
Beyond survival: advancing psycho-oncology research on fear of recurrence or progression
Imagine you are a patient with a triple-negative breast cancer. You have been informed that you present a higher risk of relapse compared to patients with another type of breast cancer, and because...
- 23 September 2026
- Published by Taylor & Francis in Future Oncology
- Vol. 22 (23) , 2735-2737
Beyond survival: advancing psycho-oncology research on fear of recurrence or progression
Imagine you are a patient with a triple-negative breast cancer. You have been informed that you present a higher risk of relapse compared to patients with another type of breast cancer, and because...
- Open Access
- 6 November 2025
- Published by Elsevier in Bulletin du Cancer
- Vol. 113 (2) , 165-174
Comment les médecins communiquent le pronostic génomique auprès des patients atteints de mélanome uvéal ? Résultats d’une étude qualitative
- 6 November 2025
- Published by Elsevier in Bulletin du Cancer
- Vol. 113 (2) , 165-174
Open AccessComment les médecins communiquent le pronostic génomique auprès des patients atteints de mélanome uvéal ? Résultats d’une étude qualitative
- 24 July 2025
- Published by Elsevier in Éthique & Santé
- Vol. 22 (3) , 153-162
L’oncogénétique – concepts théorico-cliniques et enjeux psychosociaux – Une revue de la littérature narrative
- 24 July 2025
- Published by Elsevier in Éthique & Santé
- Vol. 22 (3) , 153-162
L’oncogénétique – concepts théorico-cliniques et enjeux psychosociaux – Une revue de la littérature narrative
- Open Access
- 15 November 2024
- Published by Springer Nature in BMC Psychiatry
- Vol. 24 (1) , 1-13
Anxiety, depression and fear of cancer recurrence in uveal melanoma survivors and ophthalmologist/oncologist communication during survivorship in France – protocol of a prospective observational mixed-method study
Quality of life (QoL) in patients undergoing surveillance for uveal melanoma (UM) can be affected by psychological sequelae. Fear of cancer recurrence (FCR) may be acute especially when prognostication indicates an increased risk of metastatic recurrence. Communication with an ophthalmologist or oncologist can then play a key role in impacting QoL. In this prospective study co-designed with patient’s partners and using a mixed-method approach, 250 patients at high versus low risk of metastatic recurrence are recruited in a national UM reference centre in France. At T1, after the 6-months post-treatment surveillance visit, dyads of clinicians and eligible patients complete a questionnaire to assess their respective experience of the communication during that consultation. Patients also complete questionnaires assessing their health literacy, information preference, and satisfaction with the information received (EORTC QLQ-INFO25), genomic testing knowledge, genomic test result receipt, satisfaction with medical care (EORTC PATSAT-C33), perceived recurrence risk, anxiety and depression (HADS), fear of cancer recurrence (FCRI) and quality of life (EORTC QLQ-C30 and QLQ-OPT30). At 12-months post-treatment (T2), patients complete again the HADS, FCRI, EORTC QLQ-C30 and QLQ-OPT30. Multilevel analyses will assess the effect of satisfaction with the information received on FCR and QoL accounting for the clinicians’ and patients’ characteristics. In-depth interviews planned sequentially with ≈25 patients will deepen understanding of patients’ care experience. As information on prognosis based on medical parameters becomes widely integrated into oncology practice, this study will highlight UM survivors’ information expectations and satisfaction with communication, and its effect on FCR and QoL. Culturally adapted recommendations for doctor-patient communication will be provided for contexts of oncology surveillance involving poor prognosis in cases of recurrence. NCT06073548 (October 4, 2023).
- 15 November 2024
- Published by Springer Nature in BMC Psychiatry
- Vol. 24 (1) , 1-13
Open AccessAnxiety, depression and fear of cancer recurrence in uveal melanoma survivors and ophthalmologist/oncologist communication during survivorship in France – protocol of a prospective observational mixed-method study
Quality of life (QoL) in patients undergoing surveillance for uveal melanoma (UM) can be affected by psychological sequelae. Fear of cancer recurrence (FCR) may be acute especially when prognostication indicates an increased risk of metastatic recurrence. Communication with an ophthalmologist or oncologist can then play a key role in impacting QoL. In this prospective study co-designed with patient’s partners and using a mixed-method approach, 250 patients at high versus low risk of metastatic recurrence are recruited in a national UM reference centre in France. At T1, after the 6-months post-treatment surveillance visit, dyads of clinicians and eligible patients complete a questionnaire to assess their respective experience of the communication during that consultation. Patients also complete questionnaires assessing their health literacy, information preference, and satisfaction with the information received (EORTC QLQ-INFO25), genomic testing knowledge, genomic test result receipt, satisfaction with medical care (EORTC PATSAT-C33), perceived recurrence risk, anxiety and depression (HADS), fear of cancer recurrence (FCRI) and quality of life (EORTC QLQ-C30 and QLQ-OPT30). At 12-months post-treatment (T2), patients complete again the HADS, FCRI, EORTC QLQ-C30 and QLQ-OPT30. Multilevel analyses will assess the effect of satisfaction with the information received on FCR and QoL accounting for the clinicians’ and patients’ characteristics. In-depth interviews planned sequentially with ≈25 patients will deepen understanding of patients’ care experience. As information on prognosis based on medical parameters becomes widely integrated into oncology practice, this study will highlight UM survivors’ information expectations and satisfaction with communication, and its effect on FCR and QoL. Culturally adapted recommendations for doctor-patient communication will be provided for contexts of oncology surveillance involving poor prognosis in cases of recurrence. NCT06073548 (October 4, 2023).
- 25 October 2023
- Published by Springer Nature
- p. 21-45
Students’ Quality of Life, Resources, and Promotion
- 25 October 2023
- Published by Springer Nature
- p. 21-45
Students’ Quality of Life, Resources, and Promotion